Dapatab 5 mg (Tablet)
Unit Price: ৳ 10.00 (3 x 10: ৳ 300.00)
Strip Price: ৳ 100.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Dapagliflozin propanediol |
| Company | Ibn sina pharmaceuticals ltd |
Title
- Dapatab
Categories
- Medicine
- Diabetes Management
- SGLT2 Inhibitor
Description
- Adjunct to diet and exercise for adults with type 2 diabetes mellitus
- Inhibitor of Sodium-glucose co-transporter 2 (SGLT2)
- Reduces reabsorption of filtered glucose
- Increases urinary glucose excretion
- Recommended starting dose of 5 mg once daily for adults
- Dosage can be increased to 10 mg once daily for additional glycemic control
- Contraindicated in patients with known hypersensitivity to Dapagliflozin or severe renal impairment
- Common side effects include hypotension, ketoacidosis, acute kidney injury, hypoglycemia, genital mycotic infections, etc.
- Pregnancy category C - potential benefit justifies potential risk
- Should not be used during lactation
- Precautions for hypotension, impairment in renal function, hypoglycemia, bladder cancer, macrovascular outcomes
Dimensions
Color Options
Functions
- Improves glycemic control
- Inhibits SGLT2
- Reduces glucose reabsorption
- Increases urinary glucose excretion
- Corrects hypovolemia
- Monitors renal function
Materials
Technical Specifications
- Recommended starting dose: 5 mg once daily
- Maximum dose: 10 mg once daily
- Therapeutic Class: SGLT2 Inhibitors
- Storage Conditions: Below 30°C, protected from light
Design Elements
Usability Features
- Dosage in the morning with or without food
- Assessment of renal function prior to initiation of therapy
- Monitoring signs and symptoms during therapy
- Consideration of lower insulin dose to reduce hypoglycemia risk
- Caution in patients with a prior history of bladder cancer
- Storage in a cool, dry place protected from light